Cardiovascular risk assessment and lipid modification

Lipid modification in development documents information

Lipid modification: quality standard consultation information

Lipid modification: QS draft guidance for consultation

Lipid modification: QS draft guidance for consultation (PDF 287 KB)

Lipid modification: QS briefing paper

Lipid modification: QS briefing paper (PDF 923 KB)

Lipid modification: QS equality analysis 2

Lipid modification: QS equality analysis 2 (PDF 158 KB)

Lipid modification: topic engagement exercise information

Lipid modification: QS topic overview

Lipid modification: QS topic overview (PDF 183 KB)

Lipid modification: equality analysis 1

Lipid modification: equality analysis 1 (PDF 107 KB)

Cardiovascular risk assessment/lipid modification/secondary prevention of myocardial infarction topic overview

Secondary prevention of myocardial infarction: QS topic overview (PDF 183 KB)

Lipid modification: stakeholder list

Cardiovascular risk assessment: specialist committee members

Cardiovascular risk assessment: consultation summary report

Cardiovascular risk assessment: quality standard consultation information

Cardiovascular risk assessment: QS draft guidance for consultation

Cardiovascular risk assessment: QS draft guidance for consultation (PDF 243 KB)

Cardiovascular risk assessment: QS briefing paper

Cardiovascular risk assessment: topic engagement exercise information

Cardiovascular risk assessment: QS topic overview

Cardiovascular risk assessment: QS topic overview (PDF 183 KB)

Cardiovascular risk assessment: QSt comments proforma

Cardiovascular risk assessment: QSt comments proforma (MSWord 59 KB)

Cardiovascular risk assessment: equality analyses

Cardiovascular risk assessment: equality analysis 1

Cardiovascular risk assessment: equality analysis 1 (PDF 107 KB)

Cardiovascular risk assessment: equality analysis 3

Cardiovascular risk assessment: stakeholder list